Press Releases
Berry to Support Asia’s Growing Healthcare Market with New Facility, Center of Excellence in Bangalore, India
Berry Global Group, Inc., a leader in the design, development, and production of patient-centered healthcare solutions, will begin product production at its second manufacturing facility and healthcare center of excellence in Bangalore, India as early as April 2023. Leveraging...
Press Releases
AARDEX and Cambridge Cognition Join Forces to Bring Next-Level Adherence Oversight to Hybrid and Decentralized Clinical Trials
Adherence specialists AARDEX Group and remote research platform experts in the Clinpal team at Cambridge Cognition have teamed up to provide next-level adherence monitoring during hybrid and decentralized clinical trials (DCTs). Integrating AARDEX Group’s MEMS® dosing capture and analytics system with Cambridge...
Press Releases
Pharmapack Europe Awards Winners 2023
Pharmapack Europe (#PharmapackEU) announces the winners of the prestigious 2023 Pharmapack Awards spanning five categories across two dedicated awards.
The Health Product Awards are open to the entire pharma industry – and include two categories for ‘eco-design’ and ‘patient-centric design’...
Press Releases
Glyconics©’ novel non-invasive diabetes screening device meets primary endpoints in two clinical investigations
Award-winning medtech firm, Glyconics© has successfully completed two independent clinical studies to validate the performance and safety of its novel non-invasive diabetes screening device.
The currently embargoed ANODE01 and ANODE02 diabetes programme results will be formally announced at the annual...
Press Releases
Pharmapack Drug Delivery Index hits record high
Pharmapack Europe 2023 (February 1-2) opens at Paris Expo, Porte de Versailles (Hall 7.2) with more than 5,500 attendees and over 300 companies expected as a new report and survey points to a dramatic transformation in the industry’s outlook. The Pharmapack 2023 report’s key metric, the...
Press Releases
Andelyn Biosciences and Odylia Therapeutics Partner to Manufacture Novel Gene Therapy for Vision Loss
Andelyn Biosciences, Inc., a pioneering and patient-focused gene therapy Contract Development and Manufacturing Organization (CDMO), has partnered with Odylia Therapeutics, a nonprofit 501(c)(3) biotech focused on accelerating rare disease drug development, to manufacture a novel gene therapy (OT-004) to...
Drug Research
Moderna Granted FDA Breakthrough Therapy Designation for mRNA-1345, An Investigational Respiratory Syncytial Virus Vaccine Candidate
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced mRNA-1345, an investigational mRNA vaccine candidate for respiratory syncytial virus (RSV), has been granted Breakthrough Therapy Designation by the U.S. Food and Drug Administration (FDA) for the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read